Skip to main content
Top
Published in: Virology Journal 1/2017

Open Access 01-12-2017 | Research

Prevalence and risk of hepatitis E virus infection in the HIV population of Nepal

Authors: Ananta Shrestha, Anurag Adhikari, Manjula Bhattarai, Ramanuj Rauniyar, Jose D. Debes, André Boonstra, Thupten K. Lama, Mamun Al Mahtab, Amna Subhan Butt, Sheikh Mohammad Fazle Akbar, Nirmal Aryal, Sapana Karn, Krishna Das Manandhar, Birendra Prasad Gupta

Published in: Virology Journal | Issue 1/2017

Login to get access

Abstract

Background

Infection with the hepatitis E virus (HEV) can cause acute hepatitis in endemic areas in immune-competent hosts, as well as chronic infection in immune-compromised subjects in non-endemic areas. Most studies assessing HEV infection in HIV-infected populations have been performed in developed countries that are usually affected by HEV genotype 3. The objective of this study is to measure the prevalence and risk of acquiring HEV among HIV-infected individuals in Nepal.

Methods

We prospectively evaluated 459 Human Immunodeficiency Virus (HIV)-positive individuals from Nepal, an endemic country for HEV, for seroprevalence of HEV and assessed risk factors associated with HEV infection. All individuals were on antiretroviral therapy and healthy blood donors were used as controls.

Results

We found a high prevalence of HEV IgG (39.4%) and HEV IgM (15.3%) in HIV-positive subjects when compared to healthy HIV-negative controls: 9.5% and 4.4%, respectively (OR: 6.17, 95% CI 4.42–8.61, p < 0.001 and OR: 3.7, 95% CI 2.35–5.92, p < 0.001, respectively). Individuals residing in the Kathmandu area showed a significantly higher HEV IgG seroprevalance compared to individuals residing outside of Kathmandu (76.8% vs 11.1%, OR: 30.33, 95% CI 18.02–51.04, p = 0.001). Mean CD4 counts, HIV viral load and presence of hepatitis B surface antigen correlated with higher HEV IgM rate, while presence of hepatitis C antibody correlated with higher rate of HEV IgG in serum. Overall, individuals with HEV IgM positivity had higher levels of alanine aminotransferase (ALT) than IgM negative subjects, suggesting active acute infection. However, no specific symptoms for hepatitis were identified.

Conclusions

HIV-positive subjects living in Kathmandu are at higher risk of acquiring HEV infection as compared to the general population and to HIV-positive subjects living outside Kathmandu.
Literature
1.
go back to reference Ahmed JA, Moturi E, Spiegel P, Schilperoord M, Burton W, Kassim NH, Mohamed A, Ochieng M, Nderitu L, Navarro-Colorado C, et al. Hepatitis E outbreak, Dadaab refugee camp, Kenya, 2012. Emerg Infect Dis. 2013;19(6):1010–2.CrossRefPubMedPubMedCentral Ahmed JA, Moturi E, Spiegel P, Schilperoord M, Burton W, Kassim NH, Mohamed A, Ochieng M, Nderitu L, Navarro-Colorado C, et al. Hepatitis E outbreak, Dadaab refugee camp, Kenya, 2012. Emerg Infect Dis. 2013;19(6):1010–2.CrossRefPubMedPubMedCentral
2.
go back to reference Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, Dalton HR. Hepatitis E. Lancet. 2012;379(9835):2477–88.CrossRefPubMed Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, Dalton HR. Hepatitis E. Lancet. 2012;379(9835):2477–88.CrossRefPubMed
4.
go back to reference Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med. 2009;361(10):1025–7.CrossRefPubMed Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med. 2009;361(10):1025–7.CrossRefPubMed
5.
go back to reference Kuniholm MH, Ong E, Hogema BM, Koppelman M, Anastos K, Peters MG, Seaberg EC, Chen Y, Nelson KE, Linnen JM. Acute and chronic hepatitis E virus infection in human immunodeficiency virus-infected U.S. women. Hepatology. 2016;63(3):712–20.CrossRefPubMedPubMedCentral Kuniholm MH, Ong E, Hogema BM, Koppelman M, Anastos K, Peters MG, Seaberg EC, Chen Y, Nelson KE, Linnen JM. Acute and chronic hepatitis E virus infection in human immunodeficiency virus-infected U.S. women. Hepatology. 2016;63(3):712–20.CrossRefPubMedPubMedCentral
6.
go back to reference Shrestha A, Lama TK, Karki S, Sigdel DR, Rai U, Rauniyar SK, Al-Mahtab M, Takahashi K, Arai M, Akbar SM, et al. Hepatitis E epidemic, Biratnagar, Nepal, 2014. Emerg Infect Dis. 2015;21(4):711–3.CrossRefPubMedPubMedCentral Shrestha A, Lama TK, Karki S, Sigdel DR, Rai U, Rauniyar SK, Al-Mahtab M, Takahashi K, Arai M, Akbar SM, et al. Hepatitis E epidemic, Biratnagar, Nepal, 2014. Emerg Infect Dis. 2015;21(4):711–3.CrossRefPubMedPubMedCentral
7.
go back to reference Shrestha SM. Hepatitis E in Nepal. Kathmandu Univ Med J (KUMJ). 2006;4(4):530–44. Shrestha SM. Hepatitis E in Nepal. Kathmandu Univ Med J (KUMJ). 2006;4(4):530–44.
8.
go back to reference Shrestha SM, Shrestha S, Tsuda F, Nishizawa T, Gotanda Y, Takeda N, Okamoto H. Molecular investigation of hepatitis E virus infection in patients with acute hepatitis in Kathmandu, Nepal. J Med Virol. 2003;69(2):207–14.CrossRefPubMed Shrestha SM, Shrestha S, Tsuda F, Nishizawa T, Gotanda Y, Takeda N, Okamoto H. Molecular investigation of hepatitis E virus infection in patients with acute hepatitis in Kathmandu, Nepal. J Med Virol. 2003;69(2):207–14.CrossRefPubMed
9.
go back to reference Jacobs C, Chiluba C, Phiri C, Lisulo MM, Chomba M, Hill PC, Ijaz S, Kelly P. Seroepidemiology of hepatitis E virus infection in an urban population in Zambia: strong association with HIV and environmental enteropathy. J Infect Dis. 2014;209(5):652–7.CrossRefPubMed Jacobs C, Chiluba C, Phiri C, Lisulo MM, Chomba M, Hill PC, Ijaz S, Kelly P. Seroepidemiology of hepatitis E virus infection in an urban population in Zambia: strong association with HIV and environmental enteropathy. J Infect Dis. 2014;209(5):652–7.CrossRefPubMed
10.
go back to reference Keane F, Gompels M, Bendall R, Drayton R, Jennings L, Black J, Baragwanath G, Lin N, Henley W, Ngui SL, et al. Hepatitis E virus coinfection in patients with HIV infection. HIV Med. 2012;13(1):83–8.PubMed Keane F, Gompels M, Bendall R, Drayton R, Jennings L, Black J, Baragwanath G, Lin N, Henley W, Ngui SL, et al. Hepatitis E virus coinfection in patients with HIV infection. HIV Med. 2012;13(1):83–8.PubMed
11.
go back to reference Neukam K, Barreiro P, Macias J, Avellon A, Cifuentes C, Martin-Carbonero L, Echevarria JM, Vargas J, Soriano V, Pineda JA. Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin. Clin Infect Dis. 2013;57(3):465–8.CrossRefPubMed Neukam K, Barreiro P, Macias J, Avellon A, Cifuentes C, Martin-Carbonero L, Echevarria JM, Vargas J, Soriano V, Pineda JA. Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin. Clin Infect Dis. 2013;57(3):465–8.CrossRefPubMed
12.
go back to reference Feldt T, Sarfo FS, Zoufaly A, Phillips RO, Burchard G, van Lunzen J, Jochum J, Chadwick D, Awasom C, Claussen L, et al. Hepatitis E virus infections in HIV-infected patients in Ghana and Cameroon. J Clin Virol. 2013;58(1):18–23.CrossRefPubMed Feldt T, Sarfo FS, Zoufaly A, Phillips RO, Burchard G, van Lunzen J, Jochum J, Chadwick D, Awasom C, Claussen L, et al. Hepatitis E virus infections in HIV-infected patients in Ghana and Cameroon. J Clin Virol. 2013;58(1):18–23.CrossRefPubMed
14.
go back to reference Gupta BP, Shrestha A, Adhikari A, Lama TK, Sapkota B. Acute hepatitis E virus infection in human immunodeficiency virus-positive men and women in Nepal: not quite a rare entity. Hepatology. 2016;64(3):1006–7.CrossRefPubMed Gupta BP, Shrestha A, Adhikari A, Lama TK, Sapkota B. Acute hepatitis E virus infection in human immunodeficiency virus-positive men and women in Nepal: not quite a rare entity. Hepatology. 2016;64(3):1006–7.CrossRefPubMed
15.
go back to reference Gupta BP, Lama TK, Adhikari A, Shrestha A, Rauniyar R, Sapkota B, Thapa S, Shrestha S, Gupta PP, Manandhar KD. First report of hepatitis E virus viremia in healthy blood donors from Nepal. VirusDis. 2016; doi:10.1007/s13337-016-0331-y. Gupta BP, Lama TK, Adhikari A, Shrestha A, Rauniyar R, Sapkota B, Thapa S, Shrestha S, Gupta PP, Manandhar KD. First report of hepatitis E virus viremia in healthy blood donors from Nepal. VirusDis. 2016; doi:10.​1007/​s13337-016-0331-y.
16.
go back to reference Jothikumar N, Cromeans TL, Robertson BH, Meng XJ, Hill VR. A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. J Virol Methods. 2006;131(1):65–71.CrossRefPubMed Jothikumar N, Cromeans TL, Robertson BH, Meng XJ, Hill VR. A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. J Virol Methods. 2006;131(1):65–71.CrossRefPubMed
17.
go back to reference Shrestha SM, Shrestha S, Tsuda F, Nishizawa T, Takahashi M, Gotanda Y, Okamoto H. Genetic changes in hepatitis E virus of subtype 1a in patients with sporadic acute hepatitis E in Kathmandu, Nepal, from 1997 to 2002. J Gen Virol. 2004;85(Pt 1):97–104.CrossRefPubMed Shrestha SM, Shrestha S, Tsuda F, Nishizawa T, Takahashi M, Gotanda Y, Okamoto H. Genetic changes in hepatitis E virus of subtype 1a in patients with sporadic acute hepatitis E in Kathmandu, Nepal, from 1997 to 2002. J Gen Virol. 2004;85(Pt 1):97–104.CrossRefPubMed
18.
go back to reference Naik SR, Aggarwal R, Salunke PN, Mehrotra NN. A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull World Health Organ. 1992;70(5):597–604.PubMedPubMedCentral Naik SR, Aggarwal R, Salunke PN, Mehrotra NN. A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull World Health Organ. 1992;70(5):597–604.PubMedPubMedCentral
19.
go back to reference Neupane D, Khanal V, Sharma S, Aro AR. Perceived discrimination among people living with HIV in Nepal. J Nepal Health Res Counc. 2012;10(21):136–40.PubMed Neupane D, Khanal V, Sharma S, Aro AR. Perceived discrimination among people living with HIV in Nepal. J Nepal Health Res Counc. 2012;10(21):136–40.PubMed
20.
go back to reference Balayan MS, Fedorova OE, Mikhailov MI, Rytick PG, Eremin VF, Danilova TI, Shevelev BI, Gorbacheva EC, Pankova GY. Antibody to hepatitis E virus in HIV-infected individuals and AIDS patients. J Viral Hepat. 1997;4(4):279–83.CrossRefPubMed Balayan MS, Fedorova OE, Mikhailov MI, Rytick PG, Eremin VF, Danilova TI, Shevelev BI, Gorbacheva EC, Pankova GY. Antibody to hepatitis E virus in HIV-infected individuals and AIDS patients. J Viral Hepat. 1997;4(4):279–83.CrossRefPubMed
21.
go back to reference Fainboim H, Gonzalez J, Fassio E, Martinez A, Otegui L, Eposto M, Cahn P, Marino R, Landeira G, Suaya G, et al. Prevalence of hepatitis viruses in an anti-human immunodeficiency virus-positive population from Argentina. A multicentre study. J Viral Hepat. 1999;6(1):53–7.CrossRefPubMed Fainboim H, Gonzalez J, Fassio E, Martinez A, Otegui L, Eposto M, Cahn P, Marino R, Landeira G, Suaya G, et al. Prevalence of hepatitis viruses in an anti-human immunodeficiency virus-positive population from Argentina. A multicentre study. J Viral Hepat. 1999;6(1):53–7.CrossRefPubMed
22.
go back to reference Pischke S, Ho H, Urbanek F, Meyer-Olsen D, Suneetha PV, Manns MP, Stoll M, Wedemeyer H. Hepatitis E in HIV-positive patients in a low-endemic country. J Viral Hepat. 2010;17(8):598–9.CrossRefPubMed Pischke S, Ho H, Urbanek F, Meyer-Olsen D, Suneetha PV, Manns MP, Stoll M, Wedemeyer H. Hepatitis E in HIV-positive patients in a low-endemic country. J Viral Hepat. 2010;17(8):598–9.CrossRefPubMed
23.
go back to reference Pineda JA, Cifuentes C, Parra M, Merchante N, Perez-Navarro E, Rivero-Juarez A, Monje P, Rivero A, Macias J, Real LM. Incidence and natural history of hepatitis E virus coinfection among HIV-infected patients. AIDS. 2014;28(13):1931–7.CrossRefPubMed Pineda JA, Cifuentes C, Parra M, Merchante N, Perez-Navarro E, Rivero-Juarez A, Monje P, Rivero A, Macias J, Real LM. Incidence and natural history of hepatitis E virus coinfection among HIV-infected patients. AIDS. 2014;28(13):1931–7.CrossRefPubMed
24.
go back to reference Izopet J, Labrique AB, Basnyat B, Dalton HR, Kmush B, Heaney CD, Nelson KE, Ahmed ZB, Zaman K, Mansuy JM, et al. Hepatitis E virus seroprevalence in three hyperendemic areas: Nepal, Bangladesh and southwest France. J Clin Virol. 2015;70:39–42.CrossRefPubMed Izopet J, Labrique AB, Basnyat B, Dalton HR, Kmush B, Heaney CD, Nelson KE, Ahmed ZB, Zaman K, Mansuy JM, et al. Hepatitis E virus seroprevalence in three hyperendemic areas: Nepal, Bangladesh and southwest France. J Clin Virol. 2015;70:39–42.CrossRefPubMed
25.
go back to reference Clayson ET, Shrestha MP, Vaughn DW, Snitbhan R, Shrestha KB, Longer CF, Innis BL. Rates of hepatitis E virus infection and disease among adolescents and adults in Kathmandu, Nepal. J Infect Dis. 1997;176(3):763–6.CrossRefPubMed Clayson ET, Shrestha MP, Vaughn DW, Snitbhan R, Shrestha KB, Longer CF, Innis BL. Rates of hepatitis E virus infection and disease among adolescents and adults in Kathmandu, Nepal. J Infect Dis. 1997;176(3):763–6.CrossRefPubMed
26.
go back to reference Longer CF, Shrestha MP, MacArthy PO, Myint KSA, Hoke CH, Ticehurst J, Innis BL. Epidemiology of hepatitis E virus (HEV): a cohort study in Kathmandu, Nepal. In: Nishioka K, Suzuki H, Mishiro S, Oda T, editors. Viral hepatitis and liver disease: proceedings of the international symposium on viral hepatitis and liver disease: molecules today, more cures tomorrow, Tokyo, may 10–14, 1993 (1993 ISVHLD). Tokyo: Springer Japan; 1994. p. 409–11. Longer CF, Shrestha MP, MacArthy PO, Myint KSA, Hoke CH, Ticehurst J, Innis BL. Epidemiology of hepatitis E virus (HEV): a cohort study in Kathmandu, Nepal. In: Nishioka K, Suzuki H, Mishiro S, Oda T, editors. Viral hepatitis and liver disease: proceedings of the international symposium on viral hepatitis and liver disease: molecules today, more cures tomorrow, Tokyo, may 10–14, 1993 (1993 ISVHLD). Tokyo: Springer Japan; 1994. p. 409–11.
27.
go back to reference Harrison A, Scobie L, Crossan C, Parry R, Johnston P, Stratton J, Dickinson S, Ellis V, Hunter JG, Prescott OR, et al. Hepatitis E seroprevalence in recipients of renal transplants or haemodialysis in southwest England: a case-control study. J Med Virol. 2013;85(2):266–71.CrossRefPubMed Harrison A, Scobie L, Crossan C, Parry R, Johnston P, Stratton J, Dickinson S, Ellis V, Hunter JG, Prescott OR, et al. Hepatitis E seroprevalence in recipients of renal transplants or haemodialysis in southwest England: a case-control study. J Med Virol. 2013;85(2):266–71.CrossRefPubMed
28.
go back to reference Debes JD, Martinez Wassaf M, Pisano MB, Isa MB, Lotto M, Marianelli LG, Frassone N, Ballari E, Bohjanen PR, Hansen BE, et al. Increased hepatitis E virus Seroprevalence correlates with lower CD4+ cell counts in HIV-infected persons in Argentina. PLoS One. 2016;11(7):e0160082.CrossRefPubMedPubMedCentral Debes JD, Martinez Wassaf M, Pisano MB, Isa MB, Lotto M, Marianelli LG, Frassone N, Ballari E, Bohjanen PR, Hansen BE, et al. Increased hepatitis E virus Seroprevalence correlates with lower CD4+ cell counts in HIV-infected persons in Argentina. PLoS One. 2016;11(7):e0160082.CrossRefPubMedPubMedCentral
29.
go back to reference Chionne P, Madonna E, Pisani G, Taffon S, La Rosa G, Candido A, Dettori S, Tritarelli E, Equestre M, Bruni R, et al. Evaluation of rapid tests for diagnosis of acute hepatitis E. J Clin Virol. 2016;78:4–8.CrossRefPubMed Chionne P, Madonna E, Pisani G, Taffon S, La Rosa G, Candido A, Dettori S, Tritarelli E, Equestre M, Bruni R, et al. Evaluation of rapid tests for diagnosis of acute hepatitis E. J Clin Virol. 2016;78:4–8.CrossRefPubMed
Metadata
Title
Prevalence and risk of hepatitis E virus infection in the HIV population of Nepal
Authors
Ananta Shrestha
Anurag Adhikari
Manjula Bhattarai
Ramanuj Rauniyar
Jose D. Debes
André Boonstra
Thupten K. Lama
Mamun Al Mahtab
Amna Subhan Butt
Sheikh Mohammad Fazle Akbar
Nirmal Aryal
Sapana Karn
Krishna Das Manandhar
Birendra Prasad Gupta
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2017
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-017-0899-x

Other articles of this Issue 1/2017

Virology Journal 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.